a collaborative biosecurity summit

San Francisco Bay Area

October 4, 2019
Now coming February 2020

Thank you!

Biotechnology is moving fast.

You’ve heard the news: DNA synthesis and sequencing get cheaper every year. Standardized biological parts and affordable tools mean that you can engineer bacteria in your garage. Cultured meat is coming to a supermarket near you. The first CRISPR babies will soon be learning to walk.

Many futures are possible.

It’s now easy to imagine a future where we eradicate diseases like malaria, manufacture carbon-neutral plastics, and seed the deserts with drought-resistant crops. But we must also consider futures that include runaway gene drive extinctions, laboratory accidents we can't contain, and even the spread of engineered pathogens. We cannot launch new biotechnologies into the world and blindly hope they will disrupt it for the better. We must thoughtfully, collaboratively and creatively face the consequences of our innovation.

Its time to work together

Catalyst Biosummit will bring together synthetic biologists and policymakers, academics and biohackers, and a broad range of professionals invested in biosecurity for a day of collaborative problem-solving. We aim to catalyze a diverse community of forward-looking individuals who will work together to engineer a future enhanced by biology and not endangered by it.

About the event

This is an experimental event that hopes to create a context for sharing perspectives, building connections, and sparking collaboration. Expect a mixture of lightning talks, workshops, and structured group problem-solving, as well as space and support for attendees to convene their own meetups and brainstorming sessions.


The organizing team

Catalyst is being organized by a team of PhD students, early-career researchers, and biotechnology professionals, including the organizers behind the East Bay Biosecurity Group. The conference is supported by a grant from the Effective Altruism Long Term Future Fund. We are being advised by Dr. Megan Palmer and Dr. Kevin Esvelt and are currently seeking additional members for our advisory board. Contact us if you're interested.